| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Funder | Competition | Research | Implementation/Clinical Care | KX/ Travel | Education | Open to projects outside of Canada? | Lead must be based in Canada? | Key words | Due date | Max value | Currency | Length (months) | Website | ||||||||||||
2 | Wellcome | Infectious Disease Clinical Trial Development Award | Y | Y | N | N | N | N | This funding call seeks to support the formation of transdisciplinary teams led from Africa, South Asia or South-East Asia to develop an innovative idea for a future proposal for a late-stage clinical trial that optimises current infectious disease interventions to drive impact in low- and middle-income countries. | May 19, 2026 | 200,000 | GBP | Up to 24 | https://wellcome.org/research-funding/schemes/infectious-disease-clinical-trial-development-award | ||||||||||||
3 | National Research Foundation of South Africa (NRF) and SSHRC | South Africa-Canada Seed Grant for Collaborative Research | Y | N | Y | Y | Y | Y | The Seed Grants will support researchers affiliated with eligible South African and Canadian postsecondary institutions to build capacity, foster new and existing partnerships, and develop networks and/or consortia among the Canadian and South African research communities. PIs must have PhD. Required to have one main applicant based in SA and one in Canada. | May 28, 2026 | Up to ZAR900,000/100,000 CAD | ZAR/CAD | 24 - 36 | https://www.nrf.ac.za/wp-content/uploads/2026/04/SA-Canada_Funding_Framework-_Final-1.pdf | ||||||||||||
4 | Wellcome | Infectious Disease Clinical Trial Award: Optimising interventions for impact | Y | Y | N | N | Y | N | Lead applicant and at least one coapplicant based at an organisation in Africa, South Asia or South‑East Asia. Support transdisciplinary teams to conduct randomised controlled trials that optimise licensed pharmaceutical interventions for infectious diseases. | June 2, 2026 | 1,000,000 - 8,000,000 | GBP | 36 - 60 | https://wellcome.org/research-funding/schemes/infectious-disease-clinical-trial-award-optimising-interventions-impact#key-dates-ad87 | ||||||||||||
5 | Gates Foundation | Estimating the Global Burden of Diarrheal Diseases | N | N | N | N | Y | N | Through this RFP, the Gates Foundation seeks to support independent estimation efforts that inform the overall burden of diarrhea and pathogen-specific contributions, clarify key sources of uncertainty, and produce decision-useful estimates for policymakers, researchers, and global health partners. Applications that pair high-quality analytic output with intentional LMIC capacity building are especially encouraged. | June 16, 2026 | 1,500,000 | USD | Up to 24 | https://go.communications.gatesfoundation.org/e/701613/obal-burden-diarrheal-diseases/2b47tx/1915287966/h/LxuIXKr-FlXnIRiR2XRkahVX52nhRqU3n2gvI9kou3I | ||||||||||||
6 | CIHR | Implementation Science to Tackle Non-Communicable Diseases: Maximizing Collaboration and Coordination Beyond Healthcare System | Y | Y | N | N | Y | N | Funds implementation research focused on strategies leveraging opportunities provided by settings and sectors with and beyond the healthcare system to tackle chronic non-communicable diseases (NCDs) in low- and middle-income countries (LMICs) and/or underserved populations, including Indigenous populations in high-income countries (HICs) | June 23, 2026 | 1,000,000 | CAD | Up to 60 | https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?all=1&masterList=true&next=1&org=CIHR&prog=4475&resultCount=25&sort=program&type=EXACT&view=currentOpps&language=E | ||||||||||||
7 | Health Research BC | Match Funding | Y | N | N | N | N | Y | Applying to peer-reviewed, non-BC-government-funded research competition that requires match funding; Link to human health; Must be used in BC | 5 weeks before competition deadline | https://healthresearchbc.ca/match-funding/ | |||||||||||||||
8 | NIH | Global Infectious Disease Research Training (GID) | Y | Y | N | Y | Y | Y | Open to US institutions with LMIC partner or to LMIC institutions. Application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research (not including HIV/AIDS). | August 6, 2026 | 230,000 | USD | 60 | https://grants.nih.gov/grants/guide/pa-files/PAR-24-174.html | ||||||||||||
9 | Horizon Europe - EDCTP3 | Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence | Y | Y | N | N | Y | N | Should contribute to strengthening clinical human capital base in R&I, enhancing talent retention, knowledge sharing of best practices within the research and innovation landscape, accelerate integration of digital tools into health systems, expand and scale up validated innovations with tangible implementation at national and/or sub-regional levels. | September 2, 2026 | 15,000,000 - 18,000,000 | EUR | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-JU-GH-EDCTP3-2026-03-DIGIT-02?keywords=HORIZON-JU-GH-EDCTP3-2026&isExactMatch=true&status=31094501,31094502,31094503&order=DESC&pageNumber=1&pageSize=50&sortBy=startDate | |||||||||||||
10 | CEPI | Innovations to Prepare for Future Epidemics and Pandemics | Y | N | N | N | Y | N | For (1) innovative vaccine platforms that can transform outbreak response to Disease X, addressing needs for speed, safety/efficacy, and access; or (2) advance new vaccine candidates for CEPI priority pathogens and viral families. | Rolling until 2026 | 5,000,000 | USD | 36 - 60 | https://cepi.net/calls-for-proposals?selectedProposal=9bde4615-b7b1-5f00-a079-a3080e88a845&selectedProposal=c08cff7c-f002-506a-8afb-cc2e921056ae | ||||||||||||
11 | Addax & Oryx Foundation | N/A | N | Y | N | N | Y | N | Low success rate (1%); Root causes of poverty; Africa and Middle East; Non-profit/NGO-led; Local community involvement; Holistic (Health, education, community development, environment) | Rolling | https://addax-oryx-foundation.org/en/submit-a-project | |||||||||||||||
12 | Humanitarian Grand Challenge | Transition to Scale | Y | N | N | N | Y | N | Humanitarian crises; Health supplies and equipment; WASH; Access to data; Energy | Rolling | 3,000,000 | CAD | https://www.grandchallenges.ca/funding-opportunities/ | |||||||||||||
13 | Grand Challenges Canada | Transition to Scale | Y | Y | N | N | Y | N | Scaling innovations in Maternal and Newborn Health, Digital Health, Medical Products and Technology, Community Health Worker Models, Urban Sanitation & Hygiene, and Options for safe pregnancy termination; Requires match-funding' SSA-led | Rolling | 3,000,000 | CAD | https://www.grandchallenges.ca/funding-opportunities/ | |||||||||||||
14 | Roncalli International Foundation | Grant | N | Y | N | Y | Y | Y | Requires Canadian organization to receive funds, but partnership with implementing community | Rolling | 35,000 | CAD | 12 | https://roncalli.ca/en/grant-application/eligibility-criteria/ | ||||||||||||
15 | Nestle Foundation | Pilot Grants | Y | N | N | Y | Y | N | LMIC-based; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 20,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
16 | Nestle Foundation | Small Research Grants | Y | N | N | Y | Y | N | LMIC-based; Usually after Pilot Grant; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 50,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
17 | Nestle Foundation | Large Research Grants | Y | N | N | Y | Y | N | LMIC-based; Usually after Pilot Grant; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 300,000 | USD | 36 | https://www.nestlefoundation.org/apply.html | ||||||||||||
18 | Nestle Foundation | Training Grant | Y | N | N | Y | Y | N | MSc or PhD Student; LMIC-based; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 20,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
19 | Nestle Foundation | Re-entry Grants | Y | N | N | N | Y | N | LMIC-based; Supports return to home country; Needs support from host institution | Rolling | 50,000 | USD | 36 | https://www.nestlefoundation.org/apply.html | ||||||||||||
20 | Commonweath Fund | Project Grants | Y | Y | N | N | Y | N | Primarily US-focused; Global priorities include: models of effective primary care, policy solutions to improve health care affordability , and partners with access to data sets to complete international comparisons of access, cost, and quality of care. Clinical, policy, or implementation research | Rolling | 180,000 | USD | 12 | https://www.commonwealthfund.org/grants | ||||||||||||
21 | Fonds d'Innovation pour le Developpement | Preperation Grant | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; aims to pilot, test and evaluate the impact of projects using rigorous scientific methods; For preparing for pilot or preperation for scaling grant | Rolling | 50,000 | EUR | 6 | https://fundinnovation.dev/en/launch-project | ||||||||||||
22 | Fonds d'Innovation pour le Developpement | Pilot Grant | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; Testing innovations in real-world environment | Rolling | 200,000 | EUR | 24 | https://fundinnovation.dev/en/launch-project | ||||||||||||
23 | Fonds d'Innovation pour le Developpement | Test and Preparation for Scaling Up | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; ; Testing for impact on larger scale and evaluating cost-effectiveness | Rolling | 1,500,000 | EUR | 36 | https://fundinnovation.dev/en/launch-project | ||||||||||||
24 | Fonds d'Innovation pour le Developpement | Scaling Up | Y | N | Y | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; aims to pilot, test and evaluate the impact of projects using rigorous scientific methods; Implementation following rigorous evidence of impact and cost-effectiveness | Rolling | 4,000,000 | EUR | 36 | https://fundinnovation.dev/en/launch-project | ||||||||||||
25 | Fonds d'Innovation pour le Developpement | Transformatiom of Public Policies | N | N | Y | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; Institutionalizing innovations or building capacity of governements to design, test, and evalution innovations | Rolling | 500,000 | EUR | 24 | https://fundinnovation.dev/en/launch-project | ||||||||||||
26 | Founders Pledge | Global Health and Development Fund | N | Y | N | N | Y | N | Implementation, not research. Global health and development programs, especially programs that can, in expectation, save a life for under $4,000, avert a DALY for under $70, or double income for one person at a cost of less than $30. Note that this includes interventions that affect economic growth. We don’t necessarily require that grantees be able to point to an RCT in order to demonstrate cost-effectiveness | Rolling | 300,000 | USD | https://www.founderspledge.com/requests-for-funding | |||||||||||||
27 | Open Philanthropy | Grants - Global Health and Wellbeing: Scientific Research | Y | N | N | N | Y | N | Current topics of interest include road-spectrum antiviral drugs, vaccine development, basic immunology, some aspects of cardiovascular disease, Alzheimer’s disease, predicting mouse-to-human translation, control of inflammation, epigenetics, novel scientific tools and methods, malaria, and research on how biomedical research may be improved. | Rolling | 50,000 - 2,600,000 | USD | https://www.openphilanthropy.org/focus/scientific-research/ | |||||||||||||
28 | ||||||||||||||||||||||||||
29 | ||||||||||||||||||||||||||
30 | ||||||||||||||||||||||||||
31 | ||||||||||||||||||||||||||
32 | ||||||||||||||||||||||||||
33 | ||||||||||||||||||||||||||
34 | ||||||||||||||||||||||||||
35 | ||||||||||||||||||||||||||
36 | ||||||||||||||||||||||||||
37 | ||||||||||||||||||||||||||
38 | ||||||||||||||||||||||||||
39 | ||||||||||||||||||||||||||
40 | ||||||||||||||||||||||||||
41 | ||||||||||||||||||||||||||
42 | ||||||||||||||||||||||||||
43 | ||||||||||||||||||||||||||
44 | ||||||||||||||||||||||||||
45 | ||||||||||||||||||||||||||
46 | ||||||||||||||||||||||||||
47 | ||||||||||||||||||||||||||
48 | ||||||||||||||||||||||||||
49 | ||||||||||||||||||||||||||
50 | ||||||||||||||||||||||||||
51 | ||||||||||||||||||||||||||
52 | ||||||||||||||||||||||||||
53 | ||||||||||||||||||||||||||
54 | ||||||||||||||||||||||||||
55 | ||||||||||||||||||||||||||
56 | ||||||||||||||||||||||||||
57 | ||||||||||||||||||||||||||
58 | ||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 |